George Church’s idea is to “have the body and mind of a 22-year-old but the experience of a 130-year-old,” and himself might be one of the first volunteers to try the approach in humans.
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
Color Genomics unveils its plan to give people a peek into their genetic risk, by offering a test for hereditary cancer and high cholesterol. But, they are offering more than just that.
Geisinger Health System CEO, Dr. David Feinberg reveals health system’s pioneering precision health efforts will be recommended to every patient.
For the first time, scientists have revealed the essential genes for the most deadly human malaria parasite, Plasmodium falciparum. They have created new genomic techniques to analyse every gene in the parasite and determine which ones are indispensable.
Doctors in Germany have for the first time, successfully treated twins in utero using a biotech drug, pointing to a new way to eliminate disease.
23andMe has provided their customers with a new health portal that makes it possible to share how they manage 18 common health conditions, including depression, ADHD, migraine and asthma.
Researchers have been developing CRISPR gene editing as a potential therapeutic tool for years, but now they have turned their attention to using it in cancer diagnostics.
A team of scientists at GRAIL has announced progression towards the goal of a simple blood test being able to detect a small tumour growing in your body.
For the first time, a human mini brain has been implanted into the skull of mice and surprisingly has continued to grow.
In a rare move, the agency is looking into whether Southern Illinois University allowed experimental vaccine research to occur on university grounds—without safety precautions.
Artificial human embryos could soon be on the horizon, but what will it mean? Well, arguably the potential of such a breakthrough could herald a new biological revolution.
A literature review finds an increased risk of cancer, late-stage cancer, and mortality, with increased waiting time between a positive screening and start of diagnostic testing.